CN Patent

CN101155794A — 1-氯-4-(β-D-吡喃葡萄糖-1-基)-2-[4-((S)-四氢呋喃-3-基氧基)-苄基]-苯的晶型、其制备方法及其用于制备药物的用途

Assigned to Boehringer Ingelheim International GmbH · Expires 2008-04-02 · 18y expired

What this patent protects

本发明涉及1－氯－4－(β－D－吡喃葡萄糖－1－基)－2－[4－((S)－四氢呋喃－3－基氧基)－苄基]－苯的晶型、其制备方法，及其用于制备药物的用途。

USPTO Abstract

本发明涉及1－氯－4－(β－D－吡喃葡萄糖－1－基)－2－[4－((S)－四氢呋喃－3－基氧基)－苄基]－苯的晶型、其制备方法，及其用于制备药物的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN101155794A
Jurisdiction
CN
Classification
—
Expires
2008-04-02
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.